inovio.com Open in urlscan Pro
20.245.221.239  Public Scan

Submitted URL: https://www.flvpn.inovio.com/
Effective URL: https://inovio.com/
Submission: On December 16 via automatic, source certstream-suspicious — Scanned from US

Form analysis 2 forms found in the DOM

GET https://inovio.com/

<form role="search" method="get" class="search-form" action="https://inovio.com/">
  <input type="search" value="Search INOVIO" onblur="if(this.value=='') this.value='Search INOVIO';" onfocus="if(this.value=='Search INOVIO') this.value='';" name="s">
  <button type="submit" class="search-submit"></button>
</form>

GET https://inovio.com/

<form role="search" method="get" class="search-form" action="https://inovio.com/">
  <input type="search" value="Search INOVIO" onblur="if(this.value=='') this.value='Search INOVIO';" onfocus="if(this.value=='Search INOVIO') this.value='';" name="s">
  <button type="submit" class="search-submit"></button>
</form>

Text Content

This website is AudioEye enabled and is being optimized for accessibility. To
open the AudioEye Toolbar, press "shift + =". Some assistive technologies may
require the use of a passthrough function before this keystroke. For more
information, activate the button labeled “Explore your accessibility options”.

 * 
 * 
 * 
 * 
 * 

 * For Patients: Clinical Trials
 * Publications
 * Careers
 * Contact Us

Toggle navigation
 * About INOVIO
   * Purpose, Mission and Values
   * Leadership
   * Partnerships
 * DNA Medicines Technology
   * Optimized Plasmid Design and Delivery
   * DNA Medicines Explained
   * The Promise of DNA Medicine
   * NEXT GEN DNA MEDICINE
 * DNA Medicines Pipeline
 * Investors & Media
   * Events & Presentations
   * Stock Information
   * News Releases
   * SEC Filings
   * Analyst Coverage
   * Corporate Governance
   * Shareholder Services
   * FAQ
 * For Patients: Clinical Trials
 * Publications
 * Careers
 * Contact Us
 * 


 * About INOVIO
   * Purpose, Mission and Values
   * Leadership
   * Partnerships
 * DNA Medicines Technology
   * Optimized Plasmid Design and Delivery
   * DNA Medicines Explained
   * The Promise of DNA Medicine
   * NEXT GEN DNA MEDICINE
 * DNA Medicines Pipeline
 * Investors & Media
   * Events & Presentations
   * Stock Information
   * News Releases
   * SEC Filings
   * Analyst Coverage
   * Corporate Governance
   * Shareholder Services
   * FAQ
 * For Patients: Clinical Trials
 * Publications
 * Careers
 * Contact Us






WORKING TO
CHANGE TREATMENT
PARADIGMS AND
IMPROVE LIVES We’re developing innovative, next-generation medicines to fight
HPV-related diseases, cancer and infectious diseases. LEARN MORE DRIVING
PROGRESS
WITH CUTTING-EDGE
TECHNOLOGY Our platform features optimized design and delivery of medicines that
teach the body to manufacture its own disease-fighting tools. LEARN MORE
BUILDING ON
THE PROMISE OF
DNA MEDICINE A growing body of research indicates that DNA medicines offer many
potential advantages and are generally well-tolerated, versatile, immunogenic
and scalable.  LEARN MORE


HARNESSING THE POWER OF IN VIVO PROTEIN PRODUCTION

INOVIO is a clinical-stage biotechnology company focused on developing DNA
medicines to fight HPV-related diseases, cancer and infectious diseases. We use
proprietary technology to design DNA plasmids —small circular DNA molecules that
work like software that the body’s cells can download to learn how to produce
specific proteins to target and fight disease. Our proprietary investigational
CELLECTRA® delivery devices have been designed to optimally deliver our DNA
medicines into the body’s cells, without the use of chemical adjuvants, lipid
nanoparticles or viral vectors.




LATEST INOVIO NEWS



December 13, 2024

INOVIO ANNOUNCES PRICING OF $30 MILLION PUBLIC OFFERING

(read more)
December 12, 2024

INOVIO ANNOUNCES PROPOSED PUBLIC OFFERING

(read more)
December 3, 2024

NEW RETROSPECTIVE DATA SHOWS HALF OF RRP PATIENTS TREATED WITH INO-3107 ACHIEVED
A COMPLETE RESPONSE WHEN EVALUATED 2 AND 3 YEARS FOLLOWING INITIAL PHASE 1/2
TRIAL

(read more)

PETER KIES
CHIEF FINANCIAL OFFICER

“DNA medicine has the potential to be transformational for patients around the
world. We are dedicated to delivering on that promise.”

Learn More

MICHAEL SUMNER
Chief Medical Officer

“Across our pipeline we’re working to advance DNA medicine and develop
innovative, next-generation therapies with groundbreaking potential.”

Learn More

LAURENT HUMEAU, Ph.D.
Chief Scientific Officer

“Our research is advancing the next generation of DNA medicine technology and
driving innovation in how we treat and protect people from disease.”

Learn More




JACQUELINE SHEA, Ph.D.
PRESIDENT & CHIEF EXECUTIVE OFFICER

“As we prepare to submit our first BLA, INOVIO stands poised to make DNA
medicines a reality for patients and stakeholders. We would not be here today
without the strategic vision and innovative drive of our uniquely experienced
team.”

Learn More

PETER KIES
CHIEF FINANCIAL OFFICER

“DNA medicine has the potential to be transformational for patients around the
world. We are dedicated to delivering on that promise.”

Learn More

MICHAEL SUMNER
Chief Medical Officer

“Across our pipeline we’re working to advance DNA medicine and develop
innovative, next-generation therapies with groundbreaking potential.”

Learn More

LAURENT HUMEAU, Ph.D.
Chief Scientific Officer

“Our research is advancing the next generation of DNA medicine technology and
driving innovation in how we treat and protect people from disease.”

Learn More




JACQUELINE SHEA, Ph.D.
PRESIDENT & CHIEF EXECUTIVE OFFICER

“As we prepare to submit our first BLA, INOVIO stands poised to make DNA
medicines a reality for patients and stakeholders. We would not be here today
without the strategic vision and innovative drive of our uniquely experienced
team.”

Learn More




SUBSCRIBE FOR UPDATES FROM INOVIO
Register to receive email alerts for INOVIO press releases


 * 
 * 
 * 
 * 
 * 

 * About Inovio
 * DNA Medicines Technology
 * DNA Medicines Pipeline
 * Investors & Media
 * For Patients
 * Publications
 * Careers
 * Contact Us

 * Safe Harbor Statement
 * Expanded Access
 * Privacy Policy
 * Terms & Conditions

© Copyright 2024 INOVIO Pharmaceuticals. All rights reserved.

Opens in new window
PDF Download
Word Download
Excel Download
PowerPoint Download
Document Download
Explore your accessibility options


close carousel